160 related articles for article (PubMed ID: 19033479)
1. Risk of hepatotoxicity associated with the use of telithromycin: a signal detection using data mining algorithms.
Chen Y; Guo JJ; Healy DP; Lin X; Patel NC
Ann Pharmacother; 2008 Dec; 42(12):1791-6. PubMed ID: 19033479
[TBL] [Abstract][Full Text] [Related]
2. Telithromycin use and spontaneous reports of hepatotoxicity.
Dore DD; DiBello JR; Lapane KL
Drug Saf; 2007; 30(8):697-703. PubMed ID: 17696582
[TBL] [Abstract][Full Text] [Related]
3. Potential use of data-mining algorithms for the detection of 'surprise' adverse drug reactions.
Hauben M; Horn S; Reich L
Drug Saf; 2007; 30(2):143-55. PubMed ID: 17253879
[TBL] [Abstract][Full Text] [Related]
4. Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases.
Brinker AD; Wassel RT; Lyndly J; Serrano J; Avigan M; Lee WM; Seeff LB
Hepatology; 2009 Jan; 49(1):250-7. PubMed ID: 19085949
[TBL] [Abstract][Full Text] [Related]
5. Influence of the MedDRA hierarchy on pharmacovigilance data mining results.
Pearson RK; Hauben M; Goldsmith DI; Gould AL; Madigan D; O'Hara DJ; Reisinger SJ; Hochberg AM
Int J Med Inform; 2009 Dec; 78(12):e97-e103. PubMed ID: 19230751
[TBL] [Abstract][Full Text] [Related]
6. Reports of hyperkalemia after publication of RALES--a pharmacovigilance study.
Hauben M; Reich L; Gerrits CM
Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):775-83. PubMed ID: 16804951
[TBL] [Abstract][Full Text] [Related]
7. Telithromycin and the FDA: implications for the future.
Shlaes DM; Moellering RC
Lancet Infect Dis; 2008 Feb; 8(2):83-5. PubMed ID: 18222155
[No Abstract] [Full Text] [Related]
8. Postmarketing surveillance of potentially fatal reactions to oncology drugs: potential utility of two signal-detection algorithms.
Hauben M; Reich L; Chung S
Eur J Clin Pharmacol; 2004 Dec; 60(10):747-50. PubMed ID: 15619136
[TBL] [Abstract][Full Text] [Related]
9. Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children.
Rivkees SA; Szarfman A
J Clin Endocrinol Metab; 2010 Jul; 95(7):3260-7. PubMed ID: 20427502
[TBL] [Abstract][Full Text] [Related]
10. Endotoxin-like reactions with intravenous gentamicin: results from pharmacovigilance tools under investigation.
Hauben M; Reich L
Infect Control Hosp Epidemiol; 2005 Apr; 26(4):391-4. PubMed ID: 15865275
[TBL] [Abstract][Full Text] [Related]
11. Telithromycin: the perils of hasty adoption and persistence of off-label prescribing.
Gleason PP; Walters C; Heaton AH; Schafer JA
J Manag Care Pharm; 2007 Jun; 13(5):420-5. PubMed ID: 17605513
[TBL] [Abstract][Full Text] [Related]
12. Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system).
Alsheikh-Ali AA; Karas RH
Am J Cardiol; 2007 Feb; 99(3):379-81. PubMed ID: 17261402
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K
Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of three signal-detection algorithms using a highly inclusive reference event database.
Hochberg AM; Hauben M; Pearson RK; O'Hara DJ; Reisinger SJ; Goldsmith DI; Gould AL; Madigan D
Drug Saf; 2009; 32(6):509-25. PubMed ID: 19459718
[TBL] [Abstract][Full Text] [Related]
15. Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Subeesh V; Maheswari E; Singh H; Beulah TE; Swaroop AM
Curr Drug Saf; 2019; 14(1):21-26. PubMed ID: 30362421
[TBL] [Abstract][Full Text] [Related]
16. Brief communication: severe hepatotoxicity of telithromycin: three case reports and literature review.
Clay KD; Hanson JS; Pope SD; Rissmiller RW; Purdum PP; Banks PM
Ann Intern Med; 2006 Mar; 144(6):415-20. PubMed ID: 16481451
[TBL] [Abstract][Full Text] [Related]
17. Factors Affecting the Timing of Signal Detection of Adverse Drug Reactions.
Hashiguchi M; Imai S; Uehara K; Maruyama J; Shimizu M; Mochizuki M
PLoS One; 2015; 10(12):e0144263. PubMed ID: 26641634
[TBL] [Abstract][Full Text] [Related]
18. Acute hepatitis attack after exposure to telithromycin.
Onur O; Guneysel O; Denizbasi A; Celikel C
Clin Ther; 2007 Aug; 29(8):1725-9. PubMed ID: 17919553
[TBL] [Abstract][Full Text] [Related]
19. Commonality of drug-associated adverse events detected by 4 commonly used data mining algorithms.
Sakaeda T; Kadoyama K; Minami K; Okuno Y
Int J Med Sci; 2014; 11(5):461-5. PubMed ID: 24688309
[TBL] [Abstract][Full Text] [Related]
20. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database.
Szarfman A; Machado SG; O'Neill RT
Drug Saf; 2002; 25(6):381-92. PubMed ID: 12071774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
